PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17142350-3	2007	We hypothesized that overexpression of BMPR2 in resistance PAs would ameliorate established monocrotaline PAH.	Monocrotaline	92-105	bone morphogenetic protein receptor type 2	Homo sapiens	39-44	
32521690-9	2020	Methods: the BMPR2 expression was analyzed by Western blot analysis and immunofluorescence (IF) microscopy to determine the quantity and localization of the receptor in the lung tissue from normal control subjects and patients with hereditary or idiopathic PAH, as well as in the lungs of control rats and rats with MCT or SuHx-induced PAH.	Monocrotaline	316-319	bone morphogenetic protein receptor type 2	Homo sapiens	13-18	
31542483-4	2019	In addition, monocrotaline pyrrole (MCTP), the putative toxic metabolite of the MCT, increases the expression of BMP7, proliferating cell nuclear antigen (PCNA) and activin A receptor type 2A, but decreases bone morphogenetic protein receptor type 2 in cultured pulmonary artery smooth muscle cells (PASMC).	Monocrotaline	36-39	bone morphogenetic protein receptor type 2	Homo sapiens	207-249	
26535780-5	2015	We also evaluated whether FGFR-1 inhibition could attenuate bone morphogenetic protein type II receptor (BMPR-II) downregulation in the monocrotaline model.	Monocrotaline	136-149	bone morphogenetic protein receptor type 2	Homo sapiens	105-112